Masimo Corporation (MASI)
USD 170.63
(-1.98%)
USD 170.63
(-1.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1 Billion USD | -5.22% |
| 2022 | 1.05 Billion USD | 30.98% |
| 2021 | 808.34 Million USD | 8.79% |
| 2020 | 743.06 Million USD | 18.1% |
| 2019 | 629.17 Million USD | 9.44% |
| 2018 | 574.89 Million USD | 7.44% |
| 2017 | 535.1 Million USD | 15.37% |
| 2016 | 463.79 Million USD | 13.13% |
| 2015 | 409.98 Million USD | 4.91% |
| 2014 | 390.77 Million USD | 8.9% |
| 2013 | 358.82 Million USD | 9.98% |
| 2012 | 326.25 Million USD | 10.92% |
| 2011 | 294.13 Million USD | 2.99% |
| 2010 | 285.58 Million USD | 14.78% |
| 2009 | 248.8 Million USD | 14.33% |
| 2008 | 217.62 Million USD | 19.13% |
| 2007 | 182.68 Million USD | 12.28% |
| 2006 | 162.69 Million USD | 149.64% |
| 2005 | 65.17 Million USD | -6.03% |
| 2004 | 69.35 Million USD | 185.58% |
| 2003 | 24.28 Million USD | 20.25% |
| 2002 | 20.19 Million USD | 0.0% |
| 1999 | 300 Thousand USD | 123.08% |
| 1998 | -1.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 263.2 Million USD | 3.3% |
| 2024 Q2 | 254.8 Million USD | 5.42% |
| 2024 Q1 | 241.7 Million USD | -7.99% |
| 2023 Q2 | 221.2 Million USD | -22.33% |
| 2023 Q1 | 284.8 Million USD | -9.13% |
| 2023 FY | 1 Billion USD | -5.22% |
| 2023 Q4 | 262.7 Million USD | 11.88% |
| 2023 Q3 | 234.8 Million USD | 6.15% |
| 2022 Q3 | 282.5 Million USD | 9.41% |
| 2022 Q2 | 258.2 Million USD | 26.1% |
| 2022 Q1 | 204.76 Million USD | -4.71% |
| 2022 Q4 | 313.4 Million USD | 10.94% |
| 2022 FY | 1.05 Billion USD | 30.98% |
| 2021 FY | 808.34 Million USD | 8.79% |
| 2021 Q1 | 196.87 Million USD | 5.32% |
| 2021 Q2 | 192.91 Million USD | -2.01% |
| 2021 Q3 | 203.66 Million USD | 5.57% |
| 2021 Q4 | 214.89 Million USD | 5.51% |
| 2020 Q2 | 191.58 Million USD | 3.21% |
| 2020 Q1 | 185.62 Million USD | 11.21% |
| 2020 Q3 | 178.92 Million USD | -6.61% |
| 2020 Q4 | 186.92 Million USD | 4.47% |
| 2020 FY | 743.06 Million USD | 18.1% |
| 2019 Q3 | 156.26 Million USD | 1.25% |
| 2019 Q1 | 151.64 Million USD | 2.23% |
| 2019 Q2 | 154.33 Million USD | 1.78% |
| 2019 FY | 629.17 Million USD | 9.44% |
| 2019 Q4 | 166.92 Million USD | 6.82% |
| 2018 Q4 | 148.33 Million USD | 5.38% |
| 2018 FY | 574.89 Million USD | 7.44% |
| 2018 Q3 | 140.75 Million USD | -0.98% |
| 2018 Q1 | 143.66 Million USD | -6.63% |
| 2018 Q2 | 142.14 Million USD | -1.05% |
| 2017 FY | 535.1 Million USD | 15.37% |
| 2017 Q4 | 153.86 Million USD | 19.58% |
| 2017 Q3 | 128.66 Million USD | 0.18% |
| 2017 Q2 | 128.43 Million USD | 3.47% |
| 2017 Q1 | 124.13 Million USD | -0.16% |
| 2016 Q3 | 110.12 Million USD | -4.35% |
| 2016 Q2 | 115.13 Million USD | 0.81% |
| 2016 Q1 | 114.21 Million USD | 12.25% |
| 2016 Q4 | 124.32 Million USD | 12.9% |
| 2016 FY | 463.79 Million USD | 13.13% |
| 2015 Q3 | 102.23 Million USD | -0.65% |
| 2015 FY | 409.98 Million USD | 4.91% |
| 2015 Q4 | 101.74 Million USD | -0.48% |
| 2015 Q2 | 102.9 Million USD | -0.2% |
| 2015 Q1 | 103.1 Million USD | -5.55% |
| 2014 Q2 | 93.09 Million USD | 0.86% |
| 2014 Q3 | 96.22 Million USD | 3.36% |
| 2014 Q4 | 109.15 Million USD | 13.44% |
| 2014 FY | 390.77 Million USD | 8.9% |
| 2014 Q1 | 92.3 Million USD | 1.95% |
| 2013 Q3 | 87.47 Million USD | -4.11% |
| 2013 FY | 358.82 Million USD | 9.98% |
| 2013 Q1 | 89.58 Million USD | 2.75% |
| 2013 Q2 | 91.23 Million USD | 1.84% |
| 2013 Q4 | 90.53 Million USD | 3.49% |
| 2012 Q4 | 87.18 Million USD | 11.3% |
| 2012 Q2 | 81.43 Million USD | 2.68% |
| 2012 Q1 | 79.3 Million USD | 7.73% |
| 2012 Q3 | 78.33 Million USD | -3.81% |
| 2012 FY | 326.25 Million USD | 10.92% |
| 2011 Q2 | 75.25 Million USD | -2.06% |
| 2011 Q3 | 68.43 Million USD | -9.05% |
| 2011 Q4 | 73.61 Million USD | 7.56% |
| 2011 Q1 | 76.83 Million USD | 3.65% |
| 2011 FY | 294.13 Million USD | 2.99% |
| 2010 Q4 | 74.12 Million USD | 3.51% |
| 2010 Q1 | 69.53 Million USD | 5.65% |
| 2010 FY | 285.58 Million USD | 14.78% |
| 2010 Q2 | 70.3 Million USD | 1.1% |
| 2010 Q3 | 71.61 Million USD | 1.86% |
| 2009 Q4 | 65.81 Million USD | 5.74% |
| 2009 Q1 | 60.74 Million USD | 3.79% |
| 2009 Q2 | 59.99 Million USD | -1.24% |
| 2009 Q3 | 62.24 Million USD | 3.75% |
| 2009 FY | 248.8 Million USD | 14.33% |
| 2008 Q3 | 55.73 Million USD | 4.45% |
| 2008 Q4 | 58.52 Million USD | 5.01% |
| 2008 FY | 217.62 Million USD | 19.13% |
| 2008 Q2 | 53.36 Million USD | 6.75% |
| 2008 Q1 | 49.98 Million USD | 1.4% |
| 2007 Q3 | 45.56 Million USD | -0.42% |
| 2007 Q4 | 49.3 Million USD | 8.19% |
| 2007 Q1 | 42.05 Million USD | -27.92% |
| 2007 FY | 182.68 Million USD | 12.28% |
| 2007 Q2 | 45.76 Million USD | 8.82% |
| 2006 Q1 | 49.3 Million USD | 82.8% |
| 2006 FY | 162.69 Million USD | 149.64% |
| 2006 Q3 | 58.34 Million USD | 0.0% |
| 2006 Q4 | 58.34 Million USD | 0.0% |
| 2006 Q2 | 58.34 Million USD | 18.33% |
| 2005 Q1 | 26.97 Million USD | 0.0% |
| 2005 Q3 | 26.97 Million USD | 0.0% |
| 2005 FY | 65.17 Million USD | -6.03% |
| 2005 Q4 | 26.97 Million USD | -0.0% |
| 2005 Q2 | 26.97 Million USD | 0.0% |
| 2004 FY | 69.35 Million USD | 185.58% |
| 2003 FY | 24.28 Million USD | 20.25% |
| 2002 FY | 20.19 Million USD | 0.0% |
| 1999 Q3 | 200 Thousand USD | 0.0% |
| 1999 Q4 | 100 Thousand USD | -50.0% |
| 1999 FY | 300 Thousand USD | 123.08% |
| 1998 FY | -1.3 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -1682.257% |
| AngioDynamics, Inc. | 154.69 Million USD | -548.683% |
| AtriCure, Inc. | 300.37 Million USD | -234.088% |
| Avinger, Inc. | 2 Million USD | -49999.85% |
| Azenta, Inc. | 263.14 Million USD | -281.356% |
| BioLife Solutions, Inc. | 46.75 Million USD | -2046.432% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 57.441% |
| Daxor Corporation | 1.1 Million USD | -90842.87% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -10952.979% |
| Femasys Inc. | 691.9 Thousand USD | -144935.2% |
| GlucoTrack, Inc. | -13 Thousand USD | 7719330.777% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -1548.704% |
| Hologic, Inc. | 2.22 Billion USD | 54.956% |
| ICU Medical, Inc. | 739.87 Million USD | -35.631% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 78.782% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -5906.003% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -689.853% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 841052.326% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 841052.326% |
| Microbot Medical Inc. | -106 Thousand USD | 946798.114% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -2932.18% |
| Merit Medical Systems, Inc. | 583.87 Million USD | -71.87% |
| Nephros, Inc. | 8.4 Million USD | -11839.322% |
| NovoCure Limited | 381.05 Million USD | -163.346% |
| NEXGEL, Inc. | 619 Thousand USD | -162016.317% |
| NEXGEL, Inc. | 619 Thousand USD | -162016.317% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 179938.71% |
| OraSure Technologies, Inc. | 179.42 Million USD | -459.299% |
| Pro-Dex, Inc. | 14.55 Million USD | -6796.433% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 83240.017% |
| Predictive Oncology Inc. | 1.14 Million USD | -87519.194% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -17208.358% |
| QuidelOrtho Corporation | 1.49 Billion USD | 32.849% |
| Repligen Corporation | 315.22 Million USD | -218.341% |
| Sanara MedTech Inc. | 57.13 Million USD | -1656.3% |
| STAAR Surgical Company | 252.65 Million USD | -297.188% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 112694.923% |
| Utah Medical Products, Inc. | 30.03 Million USD | -3240.768% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 51.894% |
| Jin Medical International Ltd. | 6.78 Million USD | -14690.34% |